These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 28541926)

  • 1. Addition of omega-3 fatty acid and coenzyme Q10 to statin therapy in patients with combined dyslipidemia.
    Tóth Š; Šajty M; Pekárová T; Mughees A; Štefanič P; Katz M; Spišáková K; Pella J; Pella D
    J Basic Clin Physiol Pharmacol; 2017 Jul; 28(4):327-336. PubMed ID: 28541926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel, multi-ingredient supplement to manage elevated blood lipids in patients with no evidence of cardiovascular disease: a pilot study.
    Hobbs T; Caso R; McMahon D; Nymark M
    Altern Ther Health Med; 2014; 20(5):18-23. PubMed ID: 25141367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of efficacy and safety of combination therapy with statins and omega-3 fatty acids versus statin monotherapy in patients with dyslipidemia: A systematic review and meta-analysis.
    Choi HD; Chae SM
    Medicine (Baltimore); 2018 Dec; 97(50):e13593. PubMed ID: 30558030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of combined statin plus omega-3 fatty acid therapy for mixed dyslipidemia.
    Barter P; Ginsberg HN
    Am J Cardiol; 2008 Oct; 102(8):1040-5. PubMed ID: 18929706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of coenzyme Q10 for 24 weeks improves lipid and glycemic profile in dyslipidemic individuals.
    Zhang P; Yang C; Guo H; Wang J; Lin S; Li H; Yang Y; Ling W
    J Clin Lipidol; 2018; 12(2):417-427.e5. PubMed ID: 29454678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination therapy with statins and omega-3 fatty acids.
    Nambi V; Ballantyne CM
    Am J Cardiol; 2006 Aug; 98(4A):34i-38i. PubMed ID: 16919515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Omega-3 fatty acid ethyl esters improve low-density lipoprotein subclasses without increasing low-density lipoprotein-cholesterol levels: A phase 4, randomized study.
    Masuda D; Miyata Y; Matsui S; Yamashita S
    Atherosclerosis; 2020 Jan; 292():163-170. PubMed ID: 31809985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short-Term Efficacy (at 12 Weeks) and Long-Term Safety (up to 52 Weeks) of Omega-3 Free Fatty Acids (AZD0585) for the Treatment of Japanese Patients With Dyslipidemia　- A Randomized, Double-Blind, Placebo-Controlled, Phase III Study.
    Yokote K; Niwa K; Hakoda T; Oh F; Kajimoto Y; Fukui T; Kim H; Noda Y; Lundström T; Yajima T
    Circ J; 2020 May; 84(6):994-1003. PubMed ID: 32281579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Multimodal therapy of dyslipidemia].
    Stahn A; Hanefeld M
    Clin Res Cardiol Suppl; 2011 May; 6():10-6. PubMed ID: 22528173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coenzyme q10 liquid supplementation in dyslipidemic subjects with statin-related clinical symptoms: a double-blind, randomized, placebo-controlled study.
    Derosa G; D'Angelo A; Maffioli P
    Drug Des Devel Ther; 2019; 13():3647-3655. PubMed ID: 31695332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of massive hypertriglyceridemia resistant to PUFA and fibrates: a possible role for the coenzyme Q10?
    Cicero AF; Derosa G; Miconi A; Laghi L; Nascetti S; Gaddi A
    Biofactors; 2005; 23(1):7-14. PubMed ID: 15817994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pilot study of safety and efficacy of polyprenols in combination with coenzyme Q10 in patients with statin-induced myopathy.
    Latkovskis G; Saripo V; Sokolova E; Upite D; Vanaga I; Kletnieks U; Erglis A
    Medicina (Kaunas); 2016; 52(3):171-9. PubMed ID: 27496187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of n-3 polyunsaturated fatty acids on plasma lipid, LDL lipoperoxidation, homocysteine and inflammation indicators in diabetic dyslipidemia treated with statin + fibrate combination].
    Zeman M; Zák A; Vecka M; Tvrzická E; Písaríková A; Stanková B
    Cas Lek Cesk; 2005; 144(11):737-41. PubMed ID: 16335699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of coenzyme q10 on myopathic symptoms in patients treated with statins.
    Caso G; Kelly P; McNurlan MA; Lawson WE
    Am J Cardiol; 2007 May; 99(10):1409-12. PubMed ID: 17493470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of the addition of ezetimibe to ongoing statin therapy in modifying lipid profiles and attaining low-density lipoprotein cholesterol goals in older and elderly patients: subanalyses of data from a randomized, double-blind, placebo-controlled trial.
    Pearson T; Denke M; McBride P; Battisti WP; Brady WE; Palmisano J
    Am J Geriatr Pharmacother; 2005 Dec; 3(4):218-28. PubMed ID: 16503317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of the thyroid hormone analogue eprotirome in statin-treated dyslipidemia.
    Ladenson PW; Kristensen JD; Ridgway EC; Olsson AG; Carlsson B; Klein I; Baxter JD; Angelin B
    N Engl J Med; 2010 Mar; 362(10):906-16. PubMed ID: 20220185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma ubiquinone status and response to six-month supplementation combined with multivitamins in healthy elderly women--results of a randomized, double-blind, placebo-controlled study.
    Wolters M; Hahn A
    Int J Vitam Nutr Res; 2003 May; 73(3):207-14. PubMed ID: 12847998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of coenzyme Q10 supplementation (300 mg/day) on antioxidation and anti-inflammation in coronary artery disease patients during statins therapy: a randomized, placebo-controlled trial.
    Lee BJ; Tseng YF; Yen CH; Lin PT
    Nutr J; 2013 Nov; 12(1):142. PubMed ID: 24192015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pitavastatin: novel effects on lipid parameters.
    Chapman MJ
    Atheroscler Suppl; 2011 Nov; 12(3):277-84. PubMed ID: 22152282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and tolerability of atorvastatin/fenofibrate fixed-dose combination tablet compared with atorvastatin and fenofibrate monotherapies in patients with dyslipidemia: a 12-week, multicenter, double-blind, randomized, parallel-group study.
    Davidson MH; Rooney MW; Drucker J; Eugene Griffin H; Oosman S; Beckert M;
    Clin Ther; 2009 Dec; 31(12):2824-38. PubMed ID: 20110022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.